Matthew Rozek, 29, gains new hope with experimental gene therapy in Melbourne
Matthew Rozek, 29, recently became one of the first recipients of an experimental gene therapy for severe combined immunodeficiency (SCID) in Melbourne. This groundbreaking treatment, involving genetic editing of his stem cells, aims to restore his immune system. Rozek spent much of his life in isolation due to his condition, which is also known as 'bubble boy disease'.
Take it further — get the full app and never miss a moment of what's happening in Australia.
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
Published 14 Nov 2026, 05:00 UTC · Updated 14 Nov 2026, 05:10 UTC
Summary by OZbrief Editorial. Original report: SMH. Editorial policy · Corrections
Trending
- Melbourne art teacher Alice Krause apologizes after racist car park outburst
- Pino, the autonomous kiwi, demonstrates AI's human-like curiosity and creativity
- Advance Metals, Sky Metals launch $6M IPO for new gold company
- Opera Queensland's Into the Woods opened at Glasshouse Theatre with standout cast
- Police raid $18 million Brighton mansion linked to bikie president Balsillie
- Police investigate break-in at Chris Hemsworth’s home; three vehicles stolen